The shares were disposed of at an average price of Rs 493, valuing the transaction at Rs 19.72 crore.
The data showed that the shares were purchased by Lifecell International.
Shares of Strides Pharma settled at Rs 503.40 apiece on NSE, up 2.92 per cent from the previous close.